Cargando…
Surgical Outcomes and Prognostic Factors of G3 Pancreatic Neuroendocrine Carcinomas: A Consecutive Analysis Based on Previous Study Results
In 2017, the World Health Organization (WHO) officially defined pancreatic neuroendocrine neoplasms into well-differentiated tumors, namely G1/G2/G3 pancreatic neuroendocrine tumors, and poorly differentiated carcinomas referring to G3 pancreatic neuroendocrine carcinomas (p-NECs). However, the surg...
Autores principales: | Luo, Xinmei, Yang, Min, Tian, Bole, Liu, Xubao, Duan, Kaiti, Zhang, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181221/ https://www.ncbi.nlm.nih.gov/pubmed/35683561 http://dx.doi.org/10.3390/jcm11113176 |
Ejemplares similares
-
Surgical Outcomes, Long-Term Survivals and Staging Systems of World Health Organization G3 Pancreatic Neuroendocrine Tumors
por: Yang, Min, et al.
Publicado: (2022) -
Prognostic Factors of Small Non-Functional Pancreatic Neuroendocrine Tumors and the Risk of Lymph Node Metastasis: A Population-Level Study
por: Tan, Qingquan, et al.
Publicado: (2022) -
Pancreatic neuroendocrine tumors G3 and pancreatic neuroendocrine carcinomas: Differences in basic biology and treatment
por: Zhang, Ming-Yi, et al.
Publicado: (2020) -
Surgical results for consecutive exotropia
por: Chang, Chih-Yao, et al.
Publicado: (2017) -
Early recurrence detected by (18)F-FDG PET/CT in patients with resected pancreatic ductal adenocarcinoma
por: Wang, Li, et al.
Publicado: (2020)